---
title: FCF Healthcare & Life Sciences Venture Capital Monitor - Europe - 06/2025 published
description: FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 06/2024”. The Monitor is a monthly published overview of venture capital trends in the ... Read more
---

[Research ](https://www.fcf.de/en/resources/research)

# [FCF Healthcare & Life Sciences Venture Capital Monitor - Europe - 06/2025 published](https://www.fcf.de/en/resources/research/fcf-healthcare-life-sciences-venture-capital-monitor-europe-06-2025-published)

 Written by [FCF Healthcare & Life Sciences](https://www.fcf.de/en/resources/research/author/fcf-healthcare-life-sciences) | Aug 11, 2025 6:00:00 AM

FCF Fox Corporate Finance GmbH is delighted to publish the new “**FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 06/2024**”.

The Monitor is a monthly published overview of venture capital trends in the European Healthcare & Life Sciences sector.

As of the end of June 2025 we identified the following current VC trends in Europe:

- Total Healthcare & Life Sciences funding volume reached EUR 6,109m
- Funding volume is now 33% higher than last year, a sharp increase in funding volume vs. 2024
- Biotech/Pharma received 40% of the total investment volume (EUR 2,426m) with metabolic disorders (including Diabetes, Obesity) being the leading indication (23%)
- In June, Juvenescence (Ireland) secured the highest transaction volume with EUR 132m, followed by SpliceBio (Switzerland) with EUR 119m and Draig Therapeutics (Great Britain) with EUR 103m
- GV (United States) is the most active investor (by deal volume in 2025), followed by Alphabet (United States) and Thrive Capital (United States)

To access the full report, please click [here](https://www.fcf.de/resources/research/download-request-fcf-healthcare-life-sciences-research-series-europe?hsLang=en).

[View full post](https://www.fcf.de/en/resources/research/fcf-healthcare-life-sciences-venture-capital-monitor-europe-06-2025-published)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "FCF Healthcare & Life Sciences"
  },
  "dateModified" : "2025-11-14T13:27:05.453Z",
  "datePublished" : "2025-08-11T06:00:00Z",
  "headline" : "FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 06/2025 published",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2666,
    "url" : "https://145785926.fs1.hubspotusercontent-eu1.net/hubfs/145785926/Website/Ressourcen/Healthcare_USA-Monitor_Shutterstock_2422998617_reduziert.jpeg",
    "width" : 4000
  },
  "mainEntityOfPage" : "https://www.fcf.de/en/resources/research/fcf-healthcare-life-sciences-venture-capital-monitor-europe-06-2025-published",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Research"
  }
}
```